Petr Smisek

4PUBLICATIONS
25CO-AUTHORS
Infant and child healthHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 19, 2025
PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia Treated within the AIEOP-BFM ALL 2009 Trial: Population Pharmacokinetics and Drug Exposure.

Gudrun Würthwein, Christian Siebel, Claudia Lanvers-Kaminsky

|Dec 14, 2023
Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study.

Valentino Conter, Maria Grazia Valsecchi, Gunnar Cario

|Dec 08, 2021
Impact of Antibodies Against Polyethylene Glycol on the Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukaemia: A Population Pharmacokinetic Approach.

Christian Siebel, Claudia Lanvers-Kaminsky, Julia Alten

|Feb 17, 2021
Population Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia: Treatment Phase Dependency and Predictivity in Case of Missing Data.

Gudrun Würthwein, Claudia Lanvers-Kaminsky, Christian Siebel

Pageof 1